Back to top
more

Eventide Healthcare & Life Sciences Fd Cl A: (MF: ETAHX)

(NASDAQ Mutual Funds) As of Sep 14, 2026 05:02 PM ET

$55.86 USD

+0.50 (0.90%)

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

4-Sell of 5       4  

View All Zacks Mutual Fund Rank #1's

Latest Performance as of Aug 31, 2026

Total Return %* Percentile Rank Objective
YTD 13.19 33
3 months 12.96 40
6 months 14.69 26
1 Year 49.63 21
3 Year 18.40 17
5 Year 5.76 42
10 Year 13.99 4

* Annual for three years and beyond.

Zacks Premium Research for ETAHX

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Sell 4
MF Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

% Unrealized Gain 20.74
% Yield 0.00
% SEC Yield NA
Net Assets (Mil $) 8/31/2026 157.75
% Turnover 8/31/2026 41.00

Risk

3 Year 5 Year 10 Year
Beta 0.99 0.70 0.90
Alpha -0.10 -2.02 2.35
R Squared 0.25 0.20 0.27
Std. Dev. 24.38 24.27 26.23
Sharpe 0.63 0.18 3.00

Sector / Country Weightings

As of 8/31/2026 % of Portfolio
Health 79.67
Other 15.73
Services 3.78
Industrial Cyclical 0.82

Portfolio Holdings

Top Equity Holdings
(As of 3/31/2026)
% of Portfolio Value (Mil$)
TOTAL*OTHER 4.29 68.08
GUARDANT HEALTH INC 4.07 64.69
MIRUM PHARMACEUTICALS INC 4.02 63.82
INSMED INC 3.78 60.04
BELITE BIO INC 3.59 57.02
KYMERA THERAPEUTICS INC 3.28 52.14
VAXCYTE INC 3.03 48.09
TOTAL*OTHER EQUITIES 3.02 47.96
APOGEE THERAPEUTICS INC 2.96 46.92

Stock Holding % of Net Assets

As Of 3/31/2026
Total Issues 60
Avg. P/E 5.00
Avg. P/Book 4.82
Avg. EPS Growth NA
Avg. Market Value (Mil $) 9,067

Composition

% of Portfolio
Stocks 93.90
Foreign Stocks 8.67
Cash 1.81
Bonds 0.00
Foreign Bonds 0.00
Preferred 0.00
Convertible 0.01
Other 4.29
Foreign Hedged 0.00

Style Analysis

% of Portfolio
Large Growth 0.00
Large Value 0.00
Small Growth 11.78
Small Value 0.00
Foreign Stock 1.45
Emerging Market 0.00
Precious Metal 0.63
Intermediate Bond 27.94
Foreign Bond 0.00
High Yield Bond 2.66